Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tobramycin safety and efficacy review article.
Schwarz C, Taccetti G, Burgel PR, Mulrennan S. Schwarz C, et al. Among authors: taccetti g. Respir Med. 2022 Apr-May;195:106778. doi: 10.1016/j.rmed.2022.106778. Epub 2022 Feb 25. Respir Med. 2022. PMID: 35249787 Free article. Review.
Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols.
Taccetti G, Bianchini E, Cariani L, Buzzetti R, Costantini D, Trevisan F, Zavataro L, Campana S; Italian Group for P aeruginosa Eradication in Cystic Fibrosis. Taccetti G, et al. Thorax. 2012 Oct;67(10):853-9. doi: 10.1136/thoraxjnl-2011-200832. Epub 2012 Feb 29. Thorax. 2012. PMID: 22379071 Clinical Trial.
Mycobacterium abscessus in patients with cystic fibrosis: low impact of inter-human transmission in Italy.
Tortoli E, Kohl TA, Trovato A, Baldan R, Campana S, Cariani L, Colombo C, Costa D, Cristadoro S, Di Serio MC, Manca A, Pizzamiglio G, Rancoita PMV, Rossolini GM, Taccetti G, Teri A, Niemann S, Cirillo DM. Tortoli E, et al. Among authors: taccetti g. Eur Respir J. 2017 Jul 13;50(1):1602525. doi: 10.1183/13993003.02525-2016. Print 2017 Jul. Eur Respir J. 2017. PMID: 28705942 Free article. No abstract available.
Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis.
Stefani S, Campana S, Cariani L, Carnovale V, Colombo C, Lleo MM, Iula VD, Minicucci L, Morelli P, Pizzamiglio G, Taccetti G. Stefani S, et al. Among authors: taccetti g. Int J Med Microbiol. 2017 Sep;307(6):353-362. doi: 10.1016/j.ijmm.2017.07.004. Epub 2017 Jul 19. Int J Med Microbiol. 2017. PMID: 28754426 Review.
Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices.
Zemanick E, Burgel PR, Taccetti G, Holmes A, Ratjen F, Byrnes CA, Waters VJ, Bell SC, VanDevanter DR, Stuart Elborn J, Flume PA; Antimicrobial Resistance International Working Group in Cystic Fibrosis. Zemanick E, et al. Among authors: taccetti g. J Cyst Fibros. 2020 May;19(3):370-375. doi: 10.1016/j.jcf.2019.10.006. Epub 2019 Oct 31. J Cyst Fibros. 2020. PMID: 31680041 Free article.
Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function.
Salvatore D, Terlizzi V, Francalanci M, Taccetti G, Messore B, Biglia C, Pisi G, Calderazzo MA, Caloiero M, Pizzamiglio G, Majo F, Cresta F, Leonetti G, De Venuto D. Salvatore D, et al. Among authors: taccetti g. Respir Med. 2020 Sep;171:106073. doi: 10.1016/j.rmed.2020.106073. Epub 2020 Jul 3. Respir Med. 2020. PMID: 32846335 Free article.
163 results